TScan Therapeutics, Inc. (TCRX)
Latest TCRX Insider Trades
About TScan Therapeutics, Inc. (TCRX)
TScan Therapeutics Inc is a fully integrated clinical-stage biotechnology company focused on developing a robust pipeline of T cell receptor (TCR)-engineered T cell, or TCR-T, therapies for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.
- WALTHAM, MA
- 142
- 2021
- XNAS
90-Day SEC Filing Activity
No Form 4 activity for TCRX in the last 90 days.
TCRX Insider Transactions (Form 4)
2621 Form 4 filings on record, the earliest from Nov 19, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | Grant or award | Non- Qualified Stock Option (right to buy) | 67,000 |
Recent TCRX Form 8-K Filings
5TCRX Insider Trading - FAQ
What is the latest insider trade for TCRX?
TScan Therapeutics, Inc. (TCRX) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-05-22. The full record for TCRX runs to 21 Form 4 filings, the earliest from 2024-11-19. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying TCRX stock?
No insider purchases of TCRX were filed in the last 90 days. 7 purchases are on record for this company.
How many insiders are selling TCRX stock?
No insider sales of TCRX were filed in the last 90 days.
Where can I see TCRX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks TCRX Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow TCRX insider buys?
Create a free InsiderAlpha account and press Watch on this page to add TCRX to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity
Recent Insider Filings
10Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
- - BAKER BROS. ADVISORS LP view on EDGAR
- - Keith Woods view on EDGAR
- - Garry A. Nicholson view on EDGAR
- - Gabriela Gruia view on EDGAR
- - Katina Dorton view on EDGAR
- - Barbara Klencke view on EDGAR
- - Jason Amello view on EDGAR
- - Gavin Macbeath view on EDGAR
- - Leiden Dworak view on EDGAR
Related Companies - Recent Insider Activity
Learn More
- What is SEC Form 4?
- The filing insiders must submit within two business days of a trade, and how to read its transaction codes.
- Insider activity in Health Care
- Where TCRX's peers are being bought and sold.
- Every recent Form 4
- The full market-wide feed, updated as filings arrive from SEC EDGAR.
Track TCRX insider activity as it files
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
